2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow rindopepimut: new trials by email Literature Review of rindopepimut trials Research Report on rindopepimut
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Bevacizumab, Rindopepimut (CDX-110) with GM-CSF, KLH - Glioblastoma, Small Cell Glioblastoma | Phase 2 | Completed | Celldex Therapeutics | 127 | 2011-12-01 | 2020-02-17 |
| Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme CDX-110 with GM-CSF, Temozolomide - Malignant Glioma | Phase 2 | Completed | Celldex Therapeutics | 82 | 2007-08-01 | 2018-01-16 |
Brain Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Neoplasms (1) · Recurrence (1)
United States (2)